UBS Upgrades Palantir to 'Buy' with $180 Price Target

Analysts cite Palantir's strong commercial momentum and AI platform adoption as reasons for the upgrade.

Published on Feb. 26, 2026

UBS Group has upgraded Palantir Technologies (NASDAQ:PLTR) from a 'neutral' rating to a 'buy' rating and set a $180.00 price target for the company. The brokerage cited Palantir's rapid adoption of its Artificial Intelligence Platform (AIP) and strong commercial momentum as reasons for the upgrade.

Why it matters

The upgrade from UBS is a positive sign for Palantir, which has faced some governance and legal scrutiny recently. The company's ability to scale its AI and data integration platforms to large, repeatable commercial contracts will be key to justifying its high valuation.

The details

In a research note, UBS analysts highlighted Palantir's recent Q4 results, which beat revenue and earnings estimates with high-70% year-over-year growth in parts of the business. The analysts also pointed to Palantir's new commercial and government partnerships, including a deal with Rackspace to accelerate deployments of its Foundry and AIP platforms, as well as a project with GE Aerospace to support a supply chain contract with the U.S. Defense Logistics Agency and Air Force.

  • On Thursday, February 26, 2026, UBS Group upgraded Palantir Technologies.

The players

Palantir Technologies

An American software company that develops data integration, analytics and operational decision-making platforms for government and commercial customers.

UBS Group

A Swiss multinational investment bank and financial services company.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

What’s next

The upgrade from UBS is a positive sign for Palantir, but the company will need to continue demonstrating its ability to scale its AI and data integration platforms to large, repeatable commercial contracts in order to justify its high valuation.

The takeaway

Palantir's strong commercial momentum and rapid adoption of its AI platform have caught the attention of Wall Street, with UBS upgrading the stock to 'buy'. However, the company still faces questions around governance and legal scrutiny, as well as the need to prove it can turn pilot projects into large, recurring revenue streams.